Mediolanum International Funds’s AbbVie ABBV Stock Holding History

Mediolanum International Funds’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.9M	Buy	117,411 +40	+0%	+$8.61K	0.26%	89
2026 Q1	$25M	Buy	117,371 +42,974	+58%	+$9.53M	0.27%	93
2025 Q4	$17.1M	Buy	74,397 +4,559	+7%	+$1.04M	0.17%	146
2025 Q3	$15.6M	Sell	69,838 -71,355	-51%	-$14.5M	0.16%	144
2025 Q2	$25.7M	Sell	141,193 -29,105	-17%	-$5.41M	0.31%	74
2025 Q1	$35M	Sell	170,298 -42,556	-20%	-$8.27M	0.48%	44
2024 Q4	$37.4M	Buy	212,854 +23,922	+13%	+$4.4M	0.49%	44
2024 Q3	$36.7M	Sell	188,932 -3,267	-2%	-$610K	0.51%	39
2024 Q2	$30.3M	Sell	192,199 -64,723	-25%	-$10.7M	0.5%	42
2024 Q1	$46.3M	Buy	+256,922	New	+$44.3M	0.75%	24

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Mediolanum International Funds's ABBV Position: Q2 2026 in Review

Mediolanum International Funds increased its AbbVie (ABBV) stake by 0.03% in Q2 2026, buying an estimated $8.61K and bringing the position to 117,411 shares worth $29.9M. The position accounts for 0.26% of the portfolio, ranked #89.

Mediolanum International Funds first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $46.3M in Q1 2024. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mediolanum International Funds held 117,411 shares of AbbVie worth $29.9M as of Q2 2026.
Mediolanum International Funds bought 40 AbbVie shares in Q2 2026, an estimated $8.61K.
AbbVie made up 0.26% of Mediolanum International Funds's portfolio in Q2 2026, its #89 holding.
Mediolanum International Funds first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Mediolanum International Funds's AbbVie position peaked at $46.3M in Q1 2024.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.